Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
3.150
+0.010 (0.32%)
At close: May 12, 2025, 4:00 PM
3.120
-0.030 (-0.95%)
After-hours: May 12, 2025, 7:00 PM EDT

Phathom Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Revenue
81.8655.250.68---
Upgrade
Revenue Growth (YoY)
3055.70%8001.47%----
Upgrade
Cost of Revenue
11.277.970.17---
Upgrade
Gross Profit
70.5947.280.52---
Upgrade
Selling, General & Admin
323.13290.66117.9310162.7427.52
Upgrade
Research & Development
33.8434.0849.971.4472.3498.15
Upgrade
Operating Expenses
356.96324.75167.83172.44135.08125.67
Upgrade
Operating Income
-286.38-277.47-167.31-172.44-135.08-125.67
Upgrade
Interest Expense
-72.91-72.01-41.97-27.31-6.79-4.58
Upgrade
Interest & Investment Income
13.4915.167.882.130.041.09
Upgrade
Other Non Operating Income (Expenses)
0.01-0.01-0.19-0.11-0.060.09
Upgrade
EBT Excluding Unusual Items
-345.79-334.33-201.59-197.72-141.88-129.07
Upgrade
Other Unusual Items
-----2-
Upgrade
Pretax Income
-345.79-334.33-201.59-197.72-143.88-129.07
Upgrade
Net Income
-345.79-334.33-201.59-197.72-143.88-129.07
Upgrade
Net Income to Common
-345.79-334.33-201.59-197.72-143.88-129.07
Upgrade
Shares Outstanding (Basic)
676351393733
Upgrade
Shares Outstanding (Diluted)
676351393733
Upgrade
Shares Change (YoY)
20.41%23.18%31.11%5.72%11.36%192.32%
Upgrade
EPS (Basic)
-5.19-5.29-3.93-5.05-3.89-3.88
Upgrade
EPS (Diluted)
-5.19-5.29-3.93-5.05-3.89-3.88
Upgrade
Free Cash Flow
-282.79-266.91-139.21-147.57-148.79-70.73
Upgrade
Free Cash Flow Per Share
-4.25-4.22-2.71-3.77-4.02-2.13
Upgrade
Gross Margin
86.23%85.57%75.51%---
Upgrade
Operating Margin
-349.84%-502.18%-24532.55%---
Upgrade
Profit Margin
-422.42%-605.09%-29558.94%---
Upgrade
Free Cash Flow Margin
-345.46%-483.07%-20412.61%---
Upgrade
EBITDA
-285.62-276.67-166.74-171.82-134.56-125.34
Upgrade
D&A For EBITDA
0.760.80.580.620.520.32
Upgrade
EBIT
-286.38-277.47-167.31-172.44-135.08-125.67
Upgrade
Updated May 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q